Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Treasury Shares (2020 - 2025)

BioAtla (BCAB) has 6 years of Treasury Shares data on record, last reported at $2.5 million in Q3 2025.

  • For Q3 2025, Treasury Shares rose 61.0% year-over-year to $2.5 million; the TTM value through Sep 2025 reached $2.5 million, up 61.0%, while the annual FY2024 figure was $1.6 million, 1467.04% up from the prior year.
  • Treasury Shares reached $2.5 million in Q3 2025 per BCAB's latest filing, down from $2.6 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $2.9 million in Q1 2025 and bottomed at $99104.0 in Q4 2023.
  • Average Treasury Shares over 5 years is $1.3 million, with a median of $1.6 million recorded in 2024.
  • Peak YoY movement for Treasury Shares: plummeted 80.57% in 2023, then skyrocketed 1467.04% in 2024.
  • A 5-year view of Treasury Shares shows it stood at $975046.0 in 2021, then crashed by 47.69% to $510039.0 in 2022, then tumbled by 80.57% to $99104.0 in 2023, then surged by 1467.04% to $1.6 million in 2024, then skyrocketed by 62.46% to $2.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $2.5 million in Q3 2025, $2.6 million in Q2 2025, and $2.9 million in Q1 2025.